STOCK TITAN

UBS ETRACS Alerian MLP ETN Series B SEC Filings

AMUB NYSE

Welcome to our dedicated page for UBS ETRACS Alerian MLP ETN Series B SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (AMUB) is issued by UBS AG, a foreign private issuer that reports to the US Securities and Exchange Commission. UBS AG indicates that it files a registration statement on Form F-3, including a prospectus and supplements, for offerings of securities related to ETRACS ETNs such as AMUB. These documents set out the terms of the ETN and include a "Risk Factors" section that UBS urges investors to review before investing.

UBS AG also submits annual reports on Form 20-F and periodic reports on Form 6-K. In its Form 6-K filings, UBS provides information on capitalization, total debt issued, equity and other capital and liquidity metrics, as well as updates on regulatory developments and other corporate matters. UBS AG notes that its consolidated financial statements are prepared in accordance with IFRS Accounting Standards, and that certain 6-K reports are incorporated by reference into its Form F-3 registration statement.

For AMUB, the relevant SEC filings include the base prospectus, prospectus supplements and any pricing supplements that describe the specific terms of the ETRACS Alerian MLP Index ETN Series B. UBS’s public materials state that these offering documents are available through the SEC’s EDGAR system. They also clarify that the securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.

On this page, users can access AMUB-related SEC filings and associated issuer reports. The platform provides real-time updates from EDGAR and AI-powered summaries that explain the key points of lengthy documents, such as registration statements, prospectus supplements and UBS AG’s periodic reports. This allows investors to quickly identify disclosures that affect AMUB, including risk factor updates, capital and funding information, and other details relevant to UBS AG’s role as issuer of this senior unsecured ETN.

Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to CrowdStrike Holdings, Inc. stock due April 17, 2028. The Notes pay periodic contingent coupons only if the underlying closing level meets or exceeds a coupon barrier on observation dates and will be automatically called early if the underlying closing level on any quarterly observation date (beginning after six months) is equal to or greater than the initial level. If not called, principal repayment at maturity depends on the final level relative to a downside threshold; if the final level is below that threshold, repayment is reduced pro rata and you can lose a substantial portion or all of your investment. Trade date is April 10, 2026, settlement April 14, 2026, final valuation date April 12, 2028, and maturity April 17, 2028. The Notes are unsecured obligations of UBS and any payment is subject to UBS credit risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of CrowdStrike Holdings, Inc. The notes have a principal amount of $10 per Note and a maturity date of April 17, 2028. The issuer will pay a contingent coupon on each coupon payment date only if the underlying closing level on the applicable observation date is equal to or greater than the coupon barrier; otherwise no coupon is paid. The notes will be automatically called if the underlying closing level on any quarterly observation date (beginning after six months) is equal to or greater than the initial level. If not called, repayment at maturity depends on the final level relative to the downside threshold; if the final level is below that threshold, repayment may be less than principal and could result in a loss of some or all principal. Trade date is April 10, 2026 and expected settlement is April 14, 2026. The document is a preliminary pricing supplement dated April 10, 2026 and states the estimated initial value range of the Notes as $9.49 to $9.74.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the least performing of the Russell 2000® Index and the S&P 500® Index due on or about April 18, 2031. The Notes pay periodic contingent coupons only if both indices meet coupon barriers on quarterly observation dates and may be automatically called beginning about six months after issuance. If not called, principal is repaid at maturity only if both indices finish at or above a 70.00% downside threshold; otherwise investors suffer a loss equal to the negative return of the least performing index and could lose their entire investment. The issue price exceeds the estimated initial value and payments are subject to UBS credit risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG London Branch is offering $4,900,000 of Contingent Income Auto-Callable Securities with Memory Coupon due April 12, 2029, linked to the worst performing of Marvell Technology, Inc. common stock and TSMC American Depositary Receipts. Each security has a stated principal of $1,000 and an initial issue price of $1,000. Investors are eligible for a contingent payment of $123.75 per security (equivalent to 24.75% per annum) on specified contingent payment dates only if the closing prices of both underlyings meet the coupon barrier levels (60% of the initial prices) on the related determination dates. The securities pay no guaranteed interest or principal and expose holders to UBS credit risk; at maturity holders may receive less than principal if the worst performing underlying is below its 50% downside threshold. The offering includes a memory coupon feature, automatic early redemption if both underlyings meet call thresholds, limited secondary market liquidity, and estimated initial value below issue price.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG offers Trigger Autocallable Contingent Yield Notes linked to the common stock of Micron Technology, Inc. The Notes pay periodic contingent coupons only if the underlying closing level meets or exceeds a coupon barrier on observation dates and may be automatically called early if the underlying closes at or above the initial level on any observation date. If not called, principal repayment at maturity is contingent: full principal is returned only if the final level is at or above the downside threshold; if the final level is below that threshold, repayment declines dollar-for-dollar with the underlying return and investors could lose a substantial portion or all of their principal. Payments are unsecured obligations of UBS and depend on UBS's creditworthiness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $810,000 in Trigger Autocallable Contingent Yield Notes linked to the common stock of GE Vernova Inc. The Notes pay periodic contingent coupons only if the underlying stock closes at or above a coupon barrier on observation dates; otherwise no coupon is paid. The Notes may be automatically called quarterly (beginning ~6 months after trade) if the underlying closes at or above the initial level, in which case holders receive principal plus any contingent coupon due on the call settlement date.

If not called, repayment of principal at maturity on April 13, 2029 is contingent: full principal is paid only if the final level is at or above the downside threshold (stated as $50.00, or 50.00% of the initial level); if below, holders suffer a loss equal to the underlying return and could lose their entire investment. The Notes carry issuer credit risk of UBS and an estimated initial value of $9.77 per $10 Note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to Rivian Automotive, Inc. stock due April 13, 2027. The Notes pay a periodic contingent coupon only if the underlying closing level on each observation date meets or exceeds a coupon barrier and will be automatically called early if the underlying closes at or above the initial level on any observation date. If not called, principal is repaid at maturity only if the final level is at or above the downside threshold; otherwise repayment at maturity is reduced pro rata to the underlying return and you may lose a substantial portion or all of your investment. Payments (coupons or principal) are subject to UBS credit risk. The estimated initial value on the trade date is $9.83 per Note and minimum investment is 100 Notes at $10 per Note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Boston Scientific Corporation due April 13, 2029. The Notes pay a contingent coupon only when the underlying closing level on an observation date is at or above the coupon barrier and may be automatically called early if the underlying closes at or above the initial level on any prior observation date. If not called and the final level is below the downside threshold, principal repayment at maturity is reduced pro rata to the underlying return, potentially resulting in a substantial or total loss of your investment. The Notes have a minimum purchase of 100 Notes ($1,000), an estimated initial value of $9.76 per $10 Note, and are unsecured obligations of UBS subject to UBS credit risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG offers $3,094,000 Trigger Autocallable Contingent Yield Notes linked to the common stock of Eli Lilly and Company, due April 13, 2029. The Notes pay a periodic contingent coupon only if the closing level of the underlying on each observation date meets or exceeds the coupon barrier; otherwise no coupon is paid. The Notes are automatically called early if the underlying’s closing level on any quarterly observation date (beginning after 6 months) is equal to or greater than the initial level, in which case holders receive principal plus any contingent coupon on the related coupon payment date. If not called, repayment at maturity depends on the final level: full principal is paid if the final level is at or above the downside threshold, but principal is reduced proportionally to the underlying return if the final level is below that threshold; investors could lose a significant portion or all of their investment. Key dates: trade date April 9, 2026, expected settlement April 13, 2026, final valuation date April 11, 2029, maturity April 13, 2029. The estimated initial value per Note was $9.75, and any payment is subject to UBS credit risk and to product terms subject to postponement in the event of a market disruption event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG offers Trigger Autocallable Contingent Yield Notes linked to Micron Technology, Inc. stock due on or about April 13, 2028. The notes pay contingent coupons only if the underlying closes at or above specified coupon barriers on observation dates and can be automatically called early if the underlying closes at or above the initial level on an observation date. If not called, repayment at maturity is contingent: full principal is returned only if the final level is at or above the downside threshold; if the final level is below that threshold, principal is reduced proportionally to the underlying return, which could result in a total loss. Trade date is April 9, 2026 with settlement expected April 13, 2026. Minimum investment is 100 Notes at $10 per Note ($1,000). Estimated initial value range on the trade date is between $9.42 and $9.67. All payments are subject to UBS credit risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

How many UBS ETRACS Alerian MLP ETN Series B (AMUB) SEC filings are available on StockTitan?

StockTitan tracks 4155 SEC filings for UBS ETRACS Alerian MLP ETN Series B (AMUB), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for UBS ETRACS Alerian MLP ETN Series B (AMUB)?

The most recent SEC filing for UBS ETRACS Alerian MLP ETN Series B (AMUB) was filed on April 10, 2026.